Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schulman

Showing results (571-580 of 5,691) with videos related to

Pageof 570
Sort By:
Healthcare Informatics : the Business Magazine for Information and Communication Systems|November 6, 2010
Moving forward with clinical IT on multiple fronts. An interview with Asif Ahmad and Kevin Schulman, M.D., Duke University Health System/Duke University. Interview by Mark HaglandAsif Ahmad, Kevin Schulman
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Continuous infusion instead of bolus injections of factor concentrate?S Schulman, U Martinowitz
The Journal of Reproductive Medicine|August 1, 1985
Surgical approach to failed cervical cerclage. A report of three casesH Schulman, G Farmakides
Thrombosis and Haemostasis|April 1, 1996
The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study GroupS Schulman, B Wiman
The New England Journal of Medicine|June 30, 2000
Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation TrialS Schulman, P Lindmarker
Blood|December 19, 2018
Treatment of bleeding complications in patients on anticoagulant therapySiavash Piran, Sam Schulman
World Journal of Urology|June 29, 2002
The ageing maleC Schulman, B Lunenfeld
Advances in Renal Replacement Therapy|April 1, 1994
Hemodialysis membrane biocompatibility in acute renal failureG Schulman, R Hakim
Thrombosis Journal|October 22, 2016
Management of venous thromboembolism: an updateSiavash Piran, Sam Schulman
Frontiers in Pharmacology|March 7, 2014
CaMKII inhibitors: from research tools to therapeutic agentsPatricia Pellicena, Howard Schulman
Pageof 570

Showing results (571-580 of 5,691) with videos related to

Sort By:
Pageof 570
Healthcare Informatics : the Business Magazine for Information and Communication Systems|November 6, 2010
Moving forward with clinical IT on multiple fronts. An interview with Asif Ahmad and Kevin Schulman, M.D., Duke University Health System/Duke University. Interview by Mark HaglandAsif Ahmad, Kevin Schulman
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Continuous infusion instead of bolus injections of factor concentrate?S Schulman, U Martinowitz
The Journal of Reproductive Medicine|August 1, 1985
Surgical approach to failed cervical cerclage. A report of three casesH Schulman, G Farmakides
Thrombosis and Haemostasis|April 1, 1996
The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study GroupS Schulman, B Wiman
The New England Journal of Medicine|June 30, 2000
Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation TrialS Schulman, P Lindmarker
Blood|December 19, 2018
Treatment of bleeding complications in patients on anticoagulant therapySiavash Piran, Sam Schulman
World Journal of Urology|June 29, 2002
The ageing maleC Schulman, B Lunenfeld
Advances in Renal Replacement Therapy|April 1, 1994
Hemodialysis membrane biocompatibility in acute renal failureG Schulman, R Hakim
Thrombosis Journal|October 22, 2016
Management of venous thromboembolism: an updateSiavash Piran, Sam Schulman
Frontiers in Pharmacology|March 7, 2014
CaMKII inhibitors: from research tools to therapeutic agentsPatricia Pellicena, Howard Schulman
Pageof 570